The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of daratumumab for treating multiple myeloma in patients with high-risk cytogenetic factors: A pooled analysis using synthetic individual patient data.
 
Zixuan Zhao
No Relationships to Disclose
 
Zexin Ren
No Relationships to Disclose
 
Qian Shi
Honoraria - Chugai Pharma
Consulting or Advisory Role - Hoosier Cancer Research Network; Kronos Bio; Mirati Therapeutics; Regeneron; Yiviva
Research Funding - BMS (Inst); Celgene (Inst); Janssen (Inst); Novartis (Inst); Regeneron (Inst); Roche/Genentech (Inst)
 
Andrew Cowan
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Bristol-Myers Squibb/Celgene/Juno; HopeAI; Janssen; Sanofi; Sebia
Research Funding - Bristol-Myers Squibb/Celgene/Juno (Inst); Harpoon therapeutics (Inst); IgM Biosciences (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Nektar (Inst); Opna Bio (Inst); Regeneron (Inst); Sanofi (Inst)
 
En Xie
No Relationships to Disclose
 
Will Ma
No Relationships to Disclose